SysteMHC v.231201
Home Datasets Download Help About Update

Showing details for project SYSMHC00010



SampleID NumReplicates Organism TissueType CellType MHCAllele
SampleID NumReplicates Organism TissueType CellType MHCAllele
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_PF1_Subject_04 1 Human HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_RT_Subject_10 1 Human HLA-A02:01,HLA-A01:01,HLA-B18:01,HLA-B39:24,HLA-C05:01,HLA-C07:01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_01 3 Human HLA-A03:01,HLA-A29:02,HLA-B08:01,HLA-B44:03,HLA-C07:01,HLA-C16:01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_02 3 Human HLA-A03:01,HLA-A29:02,HLA-B08:01,HLA-B44:03,HLA-C07:01,HLA-C16:01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_03 15 Human HLA-A02:01,HLA-A29:02,HLA-B57:01,HLA-B44:03,HLA-C07:01,HLA-C16:01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 19 Human HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_05 7 Human HLA-A03:01,HLA-A11:01,HLA-B44:03,HLA-B50:01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_06 6 Human HLA-A02:01,HLA-A11:01,HLA-B40:01,HLA-B44:03,HLA-C03:01,HLA-C16:01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 9 Human HLA-A02:01,HLA-A23:01,HLA-B18:01,HLA-B44:03,HLA-C04:01,HLA-C07:01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_08 20 Human HLA-A02:01,HLA-A03:01,HLA-B07:02,HLA-C07:02
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_09 20 Human HLA-A02:01,HLA-A03:01,HLA-B07:02,HLA-C07:02
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_10 19 Human HLA-A02:01,HLA-A01:01,HLA-B18:01,HLA-B39:24,HLA-C05:01,HLA-C07:01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 20 Human HLA-A02:01,HLA-A24:02,HLA-B15:01,HLA-B73:01,HLA-C03:03,HLA-C15:05
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_12 3 Human HLA-A02:01,HLA-B13:02,HLA-B41:01,HLA-C06:02,HLA-C17:01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_13 3 Human HLA-A02:01,HLA-A11:01,HLA-B27:05,HLA-B56:01,HLA-C01:02,HLA-C02:02
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_14 4 Human HLA-A03:01,HLA-A32:01,HLA-B27:05,HLA-B45:01,HLA-C01:02,HLA-C16:01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_15 9 Human HLA-A01:01,HLA-A32:01,HLA-B08:01,HLA-C07:01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_16 3 Human HLA-A11:01,HLA-B14:02,HLA-B44:02,HLA-C05:01,HLA-C08:01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_17 3 Human HLA-A11:01,HLA-B18:03,HLA-B35:01,HLA-C04:01,HLA-C07:01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_18 3 Human HLA-A03:01,HLA-A24:02,HLA-B07:02,HLA-B27:05
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_CELG_Subject_11 3 Human HLA-A02:01,HLA-A24:02,HLA-B15:01,HLA-B73:01,HLA-C03:03,HLA-C15:05
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_C_Subject_08 3 Human HLA-A02:01,HLA-A03:01,HLA-B07:02,HLA-C07:02
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_J_Subject_09 6 Human HLA-A02:01,HLA-A03:01,HLA-B07:02,HLA-C07:02
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_MA_Subject_03 3 Human HLA-A02:01,HLA-A29:02,HLA-B57:01,HLA-B44:03,HLA-C07:01,HLA-C16:01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_PF1_Subject_04 3 Human HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_RT_Subject_10 3 Human HLA-A02:01,HLA-A01:01,HLA-B18:01,HLA-B39:24,HLA-C05:01,HLA-C07:01



Detailed view of sample SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07



ID SampleID RawFileName Organism Process Tissue Type Cell Type Culture Conditions Disease State Comments MHCClass MHCAllele PubMed ID Peptide Isolation Method Antibody Mass Spectrometer LC System iRT Peptides Acquisition Mode Fragmentation Method Gradient Gradient Length Flow Rate Replicate Number
ID SampleID RawFileName Organism Process Tissue_Type Cell_Type Culture_Conditions Disease_State Comments MHCClass MHCAllele PubMed_ID Peptide Isolation_Method Antibody Mass_Spectrometer LC_System iRT_Peptides Acquisition_Mode Fragmentation_Method Gradient Gradient_Length Flow_Rate Replicate_Number
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 SYSMHC00010_pat_SR_03062014_rep5.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02:01,HLA-A23:01,HLA-B18:01,HLA-B44:03,HLA-C04:01,HLA-C07:01 26857467 native Mild acid elution Q-Exactive Plus no DDA HCD 3-40% 151 1
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 SYSMHC00010_pat_SR_03062014_rep6.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02:01,HLA-A23:01,HLA-B18:01,HLA-B44:03,HLA-C04:01,HLA-C07:01 26857467 native Mild acid elution Q-Exactive Plus no DDA HCD 3-40% 151 2
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 SYSMHC00010_pat_SR_13052014_rep1.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02:01,HLA-A23:01,HLA-B18:01,HLA-B44:03,HLA-C04:01,HLA-C07:01 26857467 native Mild acid elution Q-Exactive Plus no DDA HCD 3-40% 151 3
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 SYSMHC00010_pat_SR_15082014_rep7.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02:01,HLA-A23:01,HLA-B18:01,HLA-B44:03,HLA-C04:01,HLA-C07:01 26857467 native Mild acid elution Q-Exactive Plus no DDA HCD 3-40% 151 4
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 SYSMHC00010_pat_SR_13052014_rep2.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02:01,HLA-A23:01,HLA-B18:01,HLA-B44:03,HLA-C04:01,HLA-C07:01 26857467 native Mild acid elution Q-Exactive Plus no DDA HCD 3-40% 151 5
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 SYSMHC00010_pat_SR_15082014_rep9_2.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02:01,HLA-A23:01,HLA-B18:01,HLA-B44:03,HLA-C04:01,HLA-C07:01 26857467 native Mild acid elution Q-Exactive Plus no DDA HCD 3-40% 151 6
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 SYSMHC00010_pat_SR_16052014_rep4.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02:01,HLA-A23:01,HLA-B18:01,HLA-B44:03,HLA-C04:01,HLA-C07:01 26857467 native Mild acid elution Q-Exactive Plus no DDA HCD 3-40% 151 7
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 SYSMHC00010_pat_SR_15082014_rep8.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02:01,HLA-A23:01,HLA-B18:01,HLA-B44:03,HLA-C04:01,HLA-C07:01 26857467 native Mild acid elution Q-Exactive Plus no DDA HCD 3-40% 151 8
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 SYSMHC00010_pat_SR_16052014_rep3.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02:01,HLA-A23:01,HLA-B18:01,HLA-B44:03,HLA-C04:01,HLA-C07:01 26857467 native Mild acid elution Q-Exactive Plus no DDA HCD 3-40% 151 9